These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 564951)

  • 1. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of functional tolerance during barbiturate physical dependency production.
    Okamoto M; Boisse NR; Rosenberg HC; Rosen R
    J Pharmacol Exp Ther; 1978 Dec; 207(3):906-15. PubMed ID: 569696
    [No Abstract]   [Full Text] [Related]  

  • 6. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 8. Recovery from dispositional and pharmacodynamic tolerance after chronic pentobarbital treatment.
    Okamoto M; Rao SN; Reyes J; Rifkind AB
    J Pharmacol Exp Ther; 1985 Oct; 235(1):26-31. PubMed ID: 4045724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat.
    Okamoto M; Rosenberg HC; Boisse NR
    J Pharmacol Exp Ther; 1975 Mar; 192(3):555-69. PubMed ID: 1120956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of individual variations in drug elimination kinetics for production of pentobarbital physical dependence.
    Okamoto M; Hinman DJ
    J Pharmacol Exp Ther; 1983 Jul; 226(1):52-6. PubMed ID: 6683313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic delta 9-tetrahydrocannabinol administration on schedule-controlled behavior of pigeons: cross-tolerance to pentobarbital and barbital.
    Chait LD; Brocco MJ; McMillan DE
    Psychopharmacology (Berl); 1981; 75(1):1-4. PubMed ID: 6272342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence.
    Siew C; Goldstein DB
    J Pharmacol Exp Ther; 1978 Mar; 204(3):541-6. PubMed ID: 564954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for the rapid induction of barbiturate tolerance.
    Mann PA; Isom GE
    Proc West Pharmacol Soc; 1978; 21():387-90. PubMed ID: 693521
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of cross-tolerance between barbiturates and phencyclidine.
    Flint BA; Ho IK
    Subst Alcohol Actions Misuse; 1980; 1(3):287-93. PubMed ID: 7347920
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence.
    Lin SC; Sutherland VC
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):215-31. PubMed ID: 562525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of p-chlorophenylalanine on the acquisition of tolerance to the hypnotic effects of pentobarbital, barbital, and ethanol.
    Khanna JM; Kalant H; Lê AD; Mayer J; LeBlanc AE
    Can J Physiol Pharmacol; 1980 Sep; 58(9):1031-41. PubMed ID: 6450628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of cocaine with barbital, pentobarbital and ethanol.
    Misra AL; Pontani RB; Vadlamani NL
    Arch Int Pharmacodyn Ther; 1989; 299():44-54. PubMed ID: 2774771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.